| Enzo |
BML-P449-0005 |
DP-AMC
|
5mg |
|
|
| Enzo |
BML-P450-0005 |
WP-AMC
|
5mg |
|
|
| Enzo |
BML-P420-0001 |
Calcitonin (salmon)
|
1mg |
|
|
| Enzo |
BML-P404-0005 |
Ac-AAVALLPAVLLALLAPYVAD-CHO
|
0.5mg |
|
|
| Enzo |
BML-P416-0001 |
Z-VAD(OMe)-FMK
|
1mg |
|
|
| Enzo |
BML-P402-0001 |
PSTAIRE peptide
|
1mg |
|
|
| Enzo |
BML-P400-0001 |
IL-1 beta precursor (110-123)
|
1mg |
|
|
| Enzo |
BML-P323-0001 |
[pTyr992] EGF receptor (988-998)
|
1mg |
|
|
| Enzo |
BML-P321-0500 |
[pTyr1146/1150] Insulin receptor (1142-1153)
|
0.5mg |
|
|
| Enzo |
BML-P318-0500 |
[pTyr1146/1150/1151] Insulin receptor (1142-1153)
|
0.5mg |
|
|
| Enzo |
BML-P320-0001 |
IRS-1 (Tyr608) peptide
|
1mg |
|
|
| Enzo |
BML-P316-0500 |
[pTyr1150] Insulin receptor (1142-1153)
|
0.5mg |
|
|
| Enzo |
BML-P317-0500 |
[pTyr1151] Insulin receptor (1142-1153)
|
0.5mg |
|
|
| Enzo |
BML-P314-0500 |
Insulin receptor (1142-1153)
|
0.5mg |
|
|
| Enzo |
BML-P315-0500 |
[pTyr1146] Insulin receptor (1142-1153)
|
0.5mg |
|
|
| Enzo |
BML-P312-0001 |
pp60v-src autophosphorylation site (phosphorylated)
|
1mg |
|
|
| Enzo |
BML-P311-0001 |
PI3K SH3 domain binding peptide
|
1mg |
|
|
| Enzo |
BML-P307-0001 |
pp60 v-src autophosphorylation site
|
1mg |
|
|
| Enzo |
BML-P308-0001 |
RR-src peptide
|
1mg |
|
|
| Enzo |
BML-P306-0500 |
Peptide A
|
0.5mg |
|
|
| Enzo |
BML-P304-0001 |
pp60 c-Src C-terminal peptide
|
1mg |
|
|
| Enzo |
BML-P305-0001 |
SOS-1 (human) (1149-1158)
|
1mg |
|
|
| Enzo |
BML-P237-0005 |
Boc-Gln-Ala-Arg-AMC
|
5mg |
|
|
| Enzo |
BML-P238-0001 |
NP-M2tide
|
1mg |
|
|
| Enzo |
BML-P239-0001 |
P-M2tide
|
1mg |
|
|
| Enzo |
BML-P240-0001 |
VEGFR 2 substrate
|
1mg |
|
|
| Enzo |
BML-P241-0001 |
VEGFR 2 substrate (biotinylated)
|
1mg |
|
|
| Enzo |
BML-P303-0005 |
Boc-Ala-Ala-Nva-SBzl
|
5mg |
|
|
| Enzo |
BML-P302-0200 |
YEEI peptide (biotinylated)
|
200µg |
|
|
| Enzo |
BML-P301-0001 |
pp60c-Src C-terminal phosphoregulatory peptide
|
1mg |
|
|
| Enzo |
BML-P300-0001 |
YEEI peptide
|
1mg |
|
|
| Enzo |
BML-P278-0100 |
MMP-3 fluorogenic substrate
|
0.1mg |
|
|
| Enzo |
BML-P277-0100 |
OMNIMMP RED fluorogenic substrate
|
100µg |
|
|
| Enzo |
BML-P276-0001 |
Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 (fluorogenic substrate)
|
1mg |
|
|
| Enzo |
BML-P275-0100 |
FA-Phe-Gly-Gly-OH (ACE substrate)
|
100mg |
|
|
| Enzo |
BML-P271-0500 |
Histone H3 (human) (5-23) amide
|
0.5mg |
|
|
| Enzo |
BML-P272-0001 |
cdc2 substrate (biotinylated)
|
1mg |
|
|
| Enzo |
BML-P270-0001 |
AMARA peptide substrate
|
1mg |
|
|
| Enzo |
BML-P267-0001 |
LRRKtide
|
1mg |
|
|
| Enzo |
BML-P268-0001 |
LRRKtide (biotinylated)
|
1mg |
|
|
| Enzo |
BML-P266-0001 |
CDK2 substrate (biotinylated)
|
1mg |
|
|
| Enzo |
BML-P264-0001 |
CDK5 substrate (biotinylated)
|
1mg |
|
|
| Enzo |
BML-P265-0001 |
CDK2 substrate
|
1mg |
|
|
| Enzo |
BML-P262-0001 |
DYRK kinase substrate (biotinylated)
|
1mg |
|
|
| Enzo |
BML-P263-0001 |
CDK5 substrate
|
1mg |
|
|
| Enzo |
BML-P261-0001 |
DYRK kinase substrate
|
1mg |
|
|
| Enzo |
BML-P259-0001 |
Src substrate 2
|
1mg |
|
|
| Enzo |
BML-P260-0001 |
Src substrate 2 (biotinylated)
|
1mg |
|
|
| Enzo |
BML-P258-0001 |
IGF 1Rtide (biotinylated)
|
1mg |
|
|
| Enzo |
BML-P257-0001 |
IGF 1Rtide
|
1mg |
|
|